ダウンロード数: 147

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
cam4.974.pdf196.02 kBAdobe PDF見る/開く
タイトル: High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation
著者: Sakamoto, Soichiro
Kawabata, Hiroshi
Kanda, Junya  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-6704-3633 (unconfirmed)
Uchiyama, Tatsuki
Mizumoto, Chisaki
Kitano, Toshiyuki
Kondo, Tadakazu  KAKEN_id  orcid https://orcid.org/0000-0002-8959-6271 (unconfirmed)
Hishizawa, Masakatsu
Tomosugi, Naohisa
Takaori-Kondo, Akifumi
著者名の別形: 川端, 浩
キーワード: Allogeneic hematopoietic stem cell transplantation
engraftment
hepcidin
iron
発行日: Jan-2017
出版者: Wiley-Blackwell
誌名: Cancer Medicine
巻: 6
号: 1
開始ページ: 120
終了ページ: 128
抄録: Iron overload is considered a risk factor for mortality in patients with hematopoietic malignancies. Hepcidin is a key regulator of systemic iron balance. We previously reported dynamic changes of serum hepcidin-25 levels in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In this study, we retrospectively analyzed the association of pretransplant hepcidin-25 levels with overall survival (OS), engraftment, and other clinical outcomes of allo-HSCT in patients with hematologic malignancies. A total of 166 patients were divided into two groups depending on their pretransplant serum hepcidin-25 levels; their median age was 49.5 years, and the median follow-up time was 46.8 months. At 3 years, the patients in the high-hepcidin group had a significantly lower OS than those in the low-hepcidin group (49.2 vs. 69.0%, respectively; P = 0.006). Multivariate analysis revealed that pretransplant serum hepcidin-25 level, sex, and disease status were independently associated with OS. The incidence of platelet engraftment was significantly lower in the high-hepcidin group than in the low-hepcidin group, whereas no significant differences were observed in neutrophil and reticulocyte engraftments between these groups. Hence, pretransplant serum hepcidin levels can be a marker for predicting delayed platelet recovery after allo-HSC
著作権等: © 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
URI: http://hdl.handle.net/2433/218756
DOI(出版社版): 10.1002/cam4.974
PubMed ID: 27905193
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。